Reposted by Meagan Fitzpatrick
📢 In DRC, we and Epicentre, our epidemiology arm, have launched BRAVO, a study following 20,000 frontline workers to assess whether an existing Ebola vaccine can offer protection against the Bundibugyo virus.
msf.org
MSF launches Ebola vaccination study among DRC frontline workers | MSF
In Ebola-hit DRC, MSF and partners, including the Ministry of Health, are launching a study vaccinating frontline workers against Ebola disease.